Menu
iCAN flagship partnership in precision cancer medicine launched
iCAN aims for discoveries and improved treatments through research at the interface of precision cancer medicine and digital health. The newly formed partnership, hosted by University of Helsinki and HUS…
iCAN receives 14 million euro grant to promote development of personalized treatments for cancer
iCAN has received a grant of 14 million euros from the Academy of Finland for its second term.
Syöpätutkimuksen lippulaiva iCANille 14 miljoonan euron rahoitus – edistää yksilöllisten hoitojen kehittämistä
iCAN on saanut Suomen Akatemialta 14 miljoonan euron jatkorahoituksen.